Changes in the business environment driven by demographic trends, regulatory reforms and advances in medical technology
First written in FY2019. 14 of 16 entries say "Restated". Latest entry: FY2025.
1 other company's latest entry also says "Restated".
- FY2025RestatedAnnual report
「The Group's business strategy, operating performance and other factors may be affected by changes in demographics and population structure, revisions to medical, health insurance and long-term care systems arising from changes in disease patterns, trends in various government regulations, and innovations in medical technology.」
The company continues to disclose the risk of changes in the business environment driven by population and disease patterns, regulatory reforms, government regulations and medical technology innovation. - FY2025-H1RestatedAnnual report
「During the interim consolidated accounting period, there were no new occurrences of major risks that management recognizes could materially affect the financial position, operating results or cash flows of the consolidated companies among the matters concerning business conditions and financial matters described in this interim report, nor any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company concludes that there were no material changes to the risk of changes in the business environment driven by demographics, regulatory reforms, government regulations and medical technology innovation. - FY2024RestatedAnnual report
「The Group's business strategy, operating performance and other factors may be affected by changes in demographics and population structure, revisions to medical, health insurance and long-term care systems arising from changes in disease patterns, trends in various government regulations, and innovations in medical technology.」
The company continues to disclose the risk of changes in the business environment driven by population and disease patterns, regulatory reforms, government regulations and medical technology innovation. - FY2024-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The company concludes that there were no material changes to the risk of changes in the business environment driven by demographics, regulatory reforms, government regulations and medical technology innovation. - FY2024-Q1RestatedAnnual report
「During the cumulative first quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The company concludes that there were no material changes to the risk of changes in the business environment driven by demographics, regulatory reforms, government regulations and medical technology innovation. - FY2023RestatedAnnual report
「The Group's business strategy, operating performance and other factors may be affected by changes in demographics and population structure, revisions to medical, health insurance and long-term care systems arising from changes in disease patterns, trends in various government regulations, and innovations in medical technology.」
The company continues to disclose the risk of changes in the business environment driven by demographics and disease patterns, regulatory reforms, government regulations and medical technology innovation. - FY2023-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The company concludes that there were no material changes to the risk of changes in the business environment driven by demographics, regulatory reforms, government regulations and medical technology innovation. - FY2023-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The company concludes that there were no material changes to the risk of changes in the business environment driven by demographics, regulatory reforms, government regulations and medical technology innovation. - FY2022-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The company concludes that there were no material changes to the risk of changes in the business environment driven by demographics, regulatory reforms and medical technology innovation. - FY2022-Q1RestatedAnnual report
「During the cumulative first quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The company concludes that there were no material changes to the risk of changes in the business environment driven by demographics, regulatory reforms and medical technology innovation. - FY2021Infectious disease outbreak risk explicitly identifiedAnnual report
「The Group's business strategy, operating performance and other factors may be affected by changes in demographics and population structure, revisions to medical, health insurance and long-term care systems arising from changes in disease patterns, trends in various government regulations, innovations in medical technology, and outbreaks of infectious diseases such as COVID-19.」
In addition to the previously identified demographics, regulatory reform and medical technology innovation risks, the company explicitly identifies infectious disease outbreaks as a business environment risk. - FY2021-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The company concludes that there were no material changes to the risk of changes in the business environment driven by demographics, regulatory reforms and medical technology innovation. - FY2021-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The company concludes that there were no material changes to the risk of changes in the business environment driven by demographics, regulatory reforms and medical technology innovation. - FY2021-Q1RestatedAnnual report
「During the cumulative first quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The company concludes that there were no material changes to the risk of changes in the business environment driven by demographics, regulatory reforms and medical technology innovation. - FY2020-Q1RestatedAnnual report
「During the cumulative first quarter of the current consolidated fiscal year, there were no newly emerging business or other risks. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company concludes that there were no material changes to the risks described in the previous fiscal year. - FY2019First statedAnnual report
「Business strategy, operating performance and other factors may be affected by changes in demographics and population structure, revisions to medical, health insurance and long-term care systems arising from changes in disease patterns, trends in various government regulations, and innovations in medical technology.」
The company identifies as risks the potential impact on business strategy and operating performance from demographics and disease patterns, medical, health insurance and long-term care systems, government regulations, and medical technology innovation.